Form 4: NeueHealth Executive Jeffrey Scherman Reports Stock Transactions
SEC Form 4 Filing
Jeffrey Scherman, Chief Accounting Officer of NeueHealth, Inc., reports the vesting and sale of common stock to cover tax obligations.
Summary
- On May 9, 2024, Jeffrey Scherman vested 343 shares of common stock.
- On May 10, 2024, Scherman sold 113 shares of common stock at a weighted average price of $6.05 to cover tax withholding obligations.
- Following these transactions, Scherman directly owns 3,670 shares of NeueHealth, Inc.
- The reported transactions involved restricted stock units that vest over three years.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by an executive, with no inherent positive or negative implications for the company's overall prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.
Stakeholder Impact
- The transactions have a minimal impact on shareholders, as they represent a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/09/2023 | One-third of the original grant amount of restricted stock units vested. |
| 05/09/2024 | 343 restricted stock units vested. |
| 05/10/2024 | 113 shares of common stock were sold at a weighted average price of $6.05. |
| 05/09/2025 | One-third of the original grant amount of restricted stock units vests. |
| 05/13/2024 | Date of the report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.